Rafferty Asset Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-183,919
Closed -$2.83M 1087
2025
Q4
$2.83M Buy
183,919
+19,713
+12% +$217K 0.01% 576
2025
Q3
$1.63M Buy
164,206
+1,516
+0.9% +$15.8K 0.01% 694
2025
Q2
$1.61M Sell
162,690
-1,681
-1% -$17.7K 0.01% 659
2025
Q1
$2.13M Sell
164,371
-84,802
-34% -$1.12M 0.01% 561
2024
Q4
$3.18M Sell
249,173
-13,185
-5% -$159K 0.01% 511
2024
Q3
$2.92M Sell
262,358
-49,328
-16% -$544K 0.01% 544
2024
Q2
$3.5M Sell
311,686
-386,221
-55% -$4.5M 0.01% 493
2024
Q1
$8.66M Buy
697,907
+157,588
+29% +$2.06M 0.03% 320
2023
Q4
$7.55M Buy
540,319
+63,685
+13% +$885K 0.03% 348
2023
Q3
$7.04M Buy
476,634
+49,558
+12% +$697K 0.04% 320
2023
Q2
$5.52M Sell
427,076
-113,963
-21% -$1.3M 0.03% 390
2023
Q1
$5.31M Sell
541,039
-105,848
-16% -$1.13M 0.04% 371
2022
Q4
$6.88M Buy
646,887
+52,070
+9% +$605K 0.06% 304
2022
Q3
$6.21M Buy
594,817
+330,400
+125% +$4.31M 0.07% 277
2022
Q2
$3.33M Sell
264,417
-284,004
-52% -$3.02M 0.03% 372
2022
Q1
$5.95M Buy
548,421
+152,838
+39% +$1.86M 0.04% 335
2021
Q4
$5.57M Buy
395,583
+218,022
+123% +$3.59M 0.03% 347
2021
Q3
$3.41M Sell
177,561
-106,590
-38% -$1.42M 0.02% 411
2021
Q2
$2.8M Sell
284,151
-63,648
-18% -$579K 0.02% 530
2021
Q1
$3.42M Buy
347,799
+215,605
+163% +$1.78M 0.02% 403
2020
Q4
$588K Sell
132,194
-263,844
-67% -$1.19M 0.01% 643
2020
Q3
$1.71M Buy
396,038
+337,240
+574% +$2.41M 0.02% 466
2020
Q2
$522K Buy
58,798
+48,256
+458% +$244K 0.01% 701
2020
Q1
$37K Sell
10,542
-78,970
-88% -$366K ﹤0.01% 582
2019
Q4
$512K Buy
+89,512
New +$479K 0.01% 683
2019
Q2
Sell
-179,751
Closed -$1.31M 817
2019
Q1
$1.31M Buy
+179,751
New +$1.76M 0.02% 497

Other funds holding DVAX

Rafferty Asset Management's DVAX Position: Q1 2026 in Review

Rafferty Asset Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 183,919 shares — an estimated $2.83M sold.

Rafferty Asset Management first reported a position in DVAX in Q1 2019 and held it in 26 quarters. The position peaked at $8.66M in Q1 2024. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Rafferty Asset Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Rafferty Asset Management sold 183,919 Dynavax Technologies shares in Q1 2026, an estimated $2.83M.
  • Rafferty Asset Management first reported a position in Dynavax Technologies in Q1 2019 and held it in 26 quarters.
  • Rafferty Asset Management's Dynavax Technologies position peaked at $8.66M in Q1 2024.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.